Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

Worley was part of a team that showed how the loss of one of the two proteins used in the test disrupts synapses and leads to ...

In the quest to understand Alzheimer's disease, recent advancements in laboratory tests are shedding light on memory loss rather than solely focusing on the traditional markers like amyloid plaques.

W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the ...

New blood test developed by researchers can not only detect Alzheimer’s disease but also determine its stage, helps ...

Panelists discuss how amyloid-targeting therapies for Alzheimer disease represent a breakthrough drug class that works by binding to and removing beta-amyloid plaques through various mechanisms ...

A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but ...

For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...

Genentech announced that new data were presented at the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s ...

A study published in Brain Communications revealed new insights into early detection of Alzheimer’s disease. Researchers have ...